OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 73 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $738 | -19.8% | 59,773 | -41.3% | 0.06% | -31.5% |
| Q2 2023 | $920 | +15.0% | 101,840 | -55.8% | 0.09% | +16.5% |
| Q1 2023 | $800 | +40.8% | 230,632 | -0.4% | 0.08% | +12.9% |
| Q4 2022 | $568 | -99.8% | 231,633 | +122.5% | 0.07% | +84.2% |
| Q3 2022 | $287,000 | -6.8% | 104,084 | +44.0% | 0.04% | -7.3% |
| Q1 2022 | $308,000 | -18.3% | 72,287 | +79.7% | 0.04% | -12.8% |
| Q4 2021 | $377,000 | – | 40,227 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |